1Lok AS, McMahon BJ. Chronic hepatitis B Hepatology, 2007,45:507-539.
2谢尧.干扰素治疗慢性乙肝关键在于免疫控制[J].中国医学论坛报,2007,11.
3Han S, Chang T, Chao Y, et al. Four-year entecavir treatment in nucleoside -naive. HbeAg (+) patients: results from studies ETV-022 and -901.58th Ann Meeting Am Association Study of Lliver diseases (AASLD), No 2 - 6,2007 Boston MA. Abstract 938.
4Takehara T, Hayashi N, Takaguchi K, et al. Efficacy and safety of 3 years treatment with entecavir in Japanese nncleosidenaive patients with chronic hepatitis B. 18th Conference Asian Pac Association Study Liver, 2008.
